Last reviewed · How we verify
NCT07316556: Vliwazell
Post-Marketing Surveillance of Vliwazell® Prowound Dressing
trial in Acute and Chronic Wounds in 208 participants. Currently enrolling.
31 January 2027
Quick facts
| Lead sponsor | Lohmann & Rauscher |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 208 |
| Start date | 11 March 2024 |
| Primary completion | 31 January 2027 |
| Estimated completion | 31 January 2027 |
| Sites | 8 locations across Germany |
Conditions studied
- Acute and Chronic Wounds — all drugs for Acute and Chronic Wounds →
Sponsor
Lohmann & Rauscher
Who can join
18 and older, any sex, with Acute and Chronic Wounds. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This PMCF study is conducted to confirm the effectiveness and safety of the wound dressing Vliwazell® Pro. The aim of the study is to validate the performance of Vliwazell® Pro within its intended purpose and certified indications during routine use, and to gather additional safety data. The study will examine how the use of the dressing affects the condition of the skin surrounding the wound, the wound status in terms of exudate, wound odor, and other parameters. Furthermore, the satisfaction of healthcare providers and patients with the application of the dressing will be assessed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07316556
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Lohmann & Rauscher trials
Trials by the same sponsor.
- NCT07211243 — Suprasorb®X+PHMB Pro vs Suprasorb®X+PHMB in Treatment of Infected Venous Leg Ulcers · NA · recruiting
- NCT05646121 — Suprasorb® A + Ag in the Treatment of Wounds at Risk of Infection and Infected Wounds · completed
- NCT03897465 — Lomatuell Pro® Versus UrgoTul® in the Management of Acute Wounds · NA · completed
- NCT03444597 — Post-Market Clinical-Follow-Up Study of Suprasorb® C Collagen Wound Dressing · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07316556 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lohmann & Rauscher
- Last refreshed: 5 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07316556.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing